Main content

    Seizure Disorder Clinical Trials

    Sutter Health participates in clinical trials related to Seizure Disorder throughout their Northern California facilities. See the listing below for an overview of current trials, including contact information. For some trials, more detailed information can be found via the title link to

    Title: A Prospective, Open-label Study of the Structure and Function of the Retina in Adult Patients with Refractory Complex Partial Seizures Treated with Vigabatrin (Sabril®) (Lundbeck, Inc., Protocol 13098A
    Description: The purpose of the study is to evaluate the change in visual fields by means of automated static perimetry and to evaluate the change in retinal structure by means of spectral domain optical coherence tomography (SD-OCT) in adult patients with refractory complex partial seizures (CPS) being treated with vigabatrin (Sabril®).
    Investigator: Kenneth Laxer, MD
    Eligibility:  Medically refractory complex partial seizures (min 2 or more/month), no pre-existing ocular disease.
    Status: Closed to enrollment
    Location: California Pacific Medical Center
    Contact:  Doug Raggett, RN 415-600-3777 Email:

    Title: RNS™ System Long-Term treatment Clinical Investigation (NeuroPace, Inc., Protocol #NP10005, DN 1009075
    Description: This is a Phase 3, open label, long term follow-up (LTFU), multicenter, noncomparative, and single arm study of brivaracetam (BRV).
    Investigator: David King-Stephens, MD
    Eligibility: Age 16 years or older Epilepsy partial onset seizures.
    Status: Active and open to enrollment
    Location: California Pacific Medical Center
    Contact: Doug Raggett, RN 415-600-3777

    > See All Neurology Clinical Trials by Condition